Skip to content
value.today

Romark Laboratories, L.C.

Total raised
$59 M
4 rounds on record
Latest round
$11 M
May 2014
First round on record
Aug 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Romark Laboratories, L.C.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2014$11 MNo. 4$10 to $50 million

Romark Laboratories, L.C.: Raise no. 4, May 2014

Investors in this round

112 investors had bought by the notice of Nov 19, 2014: 112 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $15 M offered; $4 M still to sell
Smallest investment taken
$100,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,500,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Limited Liability Company, incorporated in Florida

People named in the notice

  • Brian E. Schnieders · Executive Officer
  • Celine E. Rossignol · Executive Officer
  • Jean Francois Rossignol · Executive Officer, Director
  • Kurt Andrew Frahn · Executive Officer
  • Marc S. Ayers · Executive Officer, Director
  • W. Andrew Krusen, Jr. · Director
  • W. Seymour Holt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • International Assets Advisory, LLC (CRD 10645) · Orlando, FloridaSold in all US states
  • Source Capital Group, Inc. (CRD 36719) · Westport, ConnecticutSold in all US states
  • WFG Investments, Inc. (CRD 22704) · Dallas, TexasSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY

Remarks in the notice

  • On fees: “10% of the gross proceeds raised, a non-accountable expense allowance in an amount equal to 1.0% of gross proceeds, reimbursement of reasonable out-of-pocket expenses and a Warrant to purchase Common Units equal to 15% of the number of Class C Units issue”

Signed by Kurt Frahn, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Nov 19, 2014. Read the notice at the SEC.

equity, optionsSEC
May 2013$15 MNo. 3$10 to $50 million

Romark Laboratories, L.C.: Raise no. 3, May 2013

Investors in this round

107 investors had bought by the notice of Jun 13, 2014: 107 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,499,952
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Limited Liability Company, incorporated in Florida

People named in the notice

  • Brian E. Schnieders · Executive Officer
  • Celine E. Rossignol · Executive Officer
  • Jean Francois Rossignol · Executive Officer, Director
  • Marc S. Ayers · Executive Officer, Director
  • W. Andrew Krusen, Jr. · Director
  • W. Seymour Holt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • WFG Investments, Inc. (CRD 22704) · Dallas, TexasSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY
  • International Assets Advisory, LLC (CRD 10645) · Orlando, FloridaSold in all US states
  • Source Capital Group, Inc. (CRD 36719) · Westport, ConnecticutSold in all US states

Remarks in the notice

  • On fees: “10% commission”

Signed by Brian Schnieders, Chief Administrative Officer. Source: SEC Form D, newest notice filed Jun 13, 2014. Read the notice at the SEC.

equitySEC
Dec 2010$10 MNo. 2$2 to $10 million

Romark Laboratories, L.C.: Raise no. 2, Dec 2010

Investors in this round

126 investors had bought by the notice of Nov 18, 2011: 126 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$100,000
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,157,724
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Limited Liability Company, incorporated in Florida

People named in the notice

  • Brian E. Schnieders · Executive Officer
  • Celine E. Rossignol · Executive Officer
  • Jean Francois Rossignol · Executive Officer, Director
  • Marc S. Ayers · Executive Officer, Director
  • W. Andrew Krusen, Jr. · Director
  • W. Seymour Holt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • JHS Capital Advisors, Inc. (CRD 112097) · Tampa, FloridaSold in all US states
  • International Assets Advisors, LLC (CRD 10645) · Orlando, FloridaSold in all US states
  • WFG Investments, Inc. (CRD 22704) · Dallas, TexasSold in AR, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY
  • Pariter Securities, LLC (CRD 127836) · Guaynabo, Puerto RicoSold in CA, FL, MA, MD, NY, PR
  • Anderson & Strudwick, Incorporated (CRD 48) · Richmond, VirginiaSold in all US states
  • Source Capital Group, Inc. (CRD 36719) · Westport, ConnecticutSold in all US states

Remarks in the notice

  • On fees: “10% commission plus 2% nonaccuntable expense allowance plus a warrant to purchase an amount of Issuer's Common Units equal to 20% of the number of Class C Units issued in the Offering”
  • On the amounts: “$6,873,760 in equity and $2,773,940 in debt”

Signed by Brian Schnieders, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 18, 2011. Read the notice at the SEC.

equity, debtSEC
Aug 2009$23 MNo. 1$10 to $50 million

Romark Laboratories, L.C.: Raise no. 1, Aug 2009

Investors in this round

155 investors had bought by the notice of Jan 4, 2011: 155 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $35 M offered; $12 M still to sell
Smallest investment taken
$100,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,386,182
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Florida

People named in the notice

  • Brian S. Schnieders · Executive Officer
  • Celine S. Rossignol · Executive Officer
  • Emmet B. Keefe · Executive Officer
  • Jean Francois Rossignol · Executive Officer, Director
  • Jeff B. Crowther · Executive Officer, Director
  • Marc S. Ayers · Executive Officer, Director
  • W. Andrew Krusen, Jr. · Director
  • W. Seymour Holt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • EDI Financial, Inc. (CRD 15699) · Dallas, TexasSold in AK, AL, AR, AZ, CA, CO, CT, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, VA, WA, WV
  • GunnAllen Financial, Inc. (CRD 17609) · Tampa, FloridaSold in all US states
  • International Assets Advisors, LLC (CRD 10645) · Orlando, FloridaSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY
  • DeWaay Financial Network, LLC (CRD 30767) · Clive, IowaSold in AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY

Remarks in the notice

  • On fees: “10% of gross proceeds raised in the Offering plus $75,000, plus a warrant to purchase an amount of Issuer's Units equal to 15% of the number of Class C Units issued in the Offering”
  • On the amounts: “Of the $20 million Total Offering Amount for the first offering, $14,777,619 was sold. A second offering that is integrated with the first was conducted with an offering amount of $15,000,000, $8,334,198 of which was sold. This offering is completed.”

Signed by Brian Schnieders, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Jan 4, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Romark Laboratories, L.C. chose not to state its revenue in its newest notice of a funding round (Nov 2014).

    SEC Form D · Nov 2014

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Nov 2014

That is all the official record says: Romark Laboratories, L.C. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Romark Laboratories, L.C. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 155 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Romark Laboratories, L.C.
NameRoleNamed in
Brian E. SchniedersExecutive officerNov 2014
Celine E. RossignolExecutive officerNov 2014
Jean Francois RossignolExecutive officerNov 2014
Kurt Andrew FrahnExecutive officerNov 2014
Marc S. AyersExecutive officerNov 2014
Brian S. SchniedersExecutive officerJan 2011
Celine S. RossignolExecutive officerJan 2011
Emmet B. KeefeExecutive officerJan 2011
Jeff B. CrowtherExecutive officerJan 2011
Jean Francois RossignolDirectorNov 2014
Marc S. AyersDirectorNov 2014
W. Andrew Krusen, Jr.DirectorNov 2014
W. Seymour HoltDirectorNov 2014
Jeff B. CrowtherDirectorJan 2011